Antiretroviral Treatment in Pediatric HIV Infection in the United States From Clinical Trials to Clinical Practice
about
Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children.Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART eraAssociation of site-specific and participant-specific factors with retention of children in a long-term pediatric HIV cohort study.Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIVPubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatmentNeurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countriesTipranavir: a new protease inhibitor for the pediatric population.Predictors of resolution and persistence of renal laboratory abnormalities in pediatric HIV infectionTime to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in GhanaAntiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes.Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report.Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children.Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.Global challenges in the development and delivery of paediatric antiretrovirals.Antiretroviral therapy for children: challenges and opportunities.The Use of the Medical Dictionary for Regulatory Activities in the Identification of Mitochondrial Dysfunction in HIV-Infected Children.A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infectionChronic kidney disease associated with perinatal HIV infection in children and adolescentsIncidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era.Do-not-resuscitate orders and/or hospice care, psychological health, and quality of life among children/adolescents with acquired immune deficiency syndrome.Trends in antiretroviral drug use during pregnancy among HIV-infected women on medicaid: 2000-2007.Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in AccraUsing Technology to Improve Adherence to HIV Medications in Transitional Age Youth: Research Reviewed, Methods Tried, Lessons Learned
P2860
Q33381965-54A16C9C-A1E2-4F30-9BAE-DBDCA5309992Q33572442-966953F0-3BF5-4E21-A6D0-1B60E0BF09B5Q33822738-D2168624-BD2A-404D-BEAC-8218F86BF719Q34036150-EF50A980-C846-4E04-A1E7-53E70B3A3F36Q34083742-A2F4975E-4807-4322-9015-F3259AA39D2DQ34181048-AB31C9C7-510D-4C26-9BDE-A7A6FE933572Q34513045-D4EF8DA2-D9C6-42CC-950E-B0D25FE58328Q34601313-79DEAC1E-2D43-427C-9FDB-EF67B2D9D264Q34993406-944B31F3-651A-4423-8380-20419CE16FA6Q35071036-BC4EB59D-A293-483A-8F9C-3588A425687BQ35074791-A71B6FBD-9681-4ED0-9597-ABB9759984BBQ35923526-084E6D6F-F49C-47E0-840B-BADB5E041859Q36048997-B246EB66-2E84-4454-8231-C189C4A5EBE1Q36369132-C4950823-1DD1-4B08-A73A-AB5FA5BA24E8Q36800408-5D350878-BFAB-49CC-8F0B-B1D9CF07B853Q36806770-F8782877-463D-4663-B629-BD9209E5B4A1Q36929688-6B2A4DF6-2EB8-4C16-B49F-E61DFDBC29AFQ36975397-7AE4AF0C-C14B-41B4-86D3-D38E9E4DFFEFQ37024731-A5CE8B57-69C9-41EC-B71A-4225A53886C1Q37315190-53C504DC-4509-4373-934A-D924A3123F36Q37435088-2C6ADE47-1FBA-4BED-86B5-9A67ADA45FF7Q37587959-B4A28456-2618-4221-8FB5-C1E3C8E84468Q39244930-E55519B1-724A-4093-9345-3646E4F386DDQ57827269-99FE647D-157C-4A73-9D7F-4AFE9469A6FF
P2860
Antiretroviral Treatment in Pediatric HIV Infection in the United States From Clinical Trials to Clinical Practice
description
article publié dans la revue scientifique Journal of the American Medical Association
@fr
im Mai 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Journal of the American Medical Association
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2005
@uk
name
Antiretroviral Treatment in Pe ...... al Trials to Clinical Practice
@en
Antiretroviral Treatment in Pe ...... al Trials to Clinical Practice
@nl
type
label
Antiretroviral Treatment in Pe ...... al Trials to Clinical Practice
@en
Antiretroviral Treatment in Pe ...... al Trials to Clinical Practice
@nl
prefLabel
Antiretroviral Treatment in Pe ...... al Trials to Clinical Practice
@en
Antiretroviral Treatment in Pe ...... al Trials to Clinical Practice
@nl
P2093
P356
P1476
Antiretroviral treatment in pe ...... al trials to clinical practice
@en
P2093
George R Seage
Kenneth McIntosh
PACTG 219C Team
Paige Williams
Russell Van Dyke
P304
P356
10.1001/JAMA.293.18.2213
P407
P577
2005-05-01T00:00:00Z